• Adoben

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol	50 mg

  ATC code: N02AX06

  Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH

• Adoben

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol hemihydrate	156.51 mg

  ATC code: N02AX06

  Manufacturer: Krka d.d., Novo mesto TAD Pharma GmbH

• Adoben

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol hemihydrate	234.76 mg

  ATC code: N02AX06

  Manufacturer: Krka d.d., Novo mesto TAD Pharma GmbH

• Adoben

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol hemihydrate	313.01 mg

  ATC code: N02AX06

  Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH

• Adoben

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol hemihydrate	391.27 mg

  ATC code: N02AX06

  Manufacturer: Krka d.d., Novo mesto TAD Pharma GmbH

• Binatta

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol phosphate	153.139 mg

  ATC code: N02AX06

  Manufacturer: Centrafarm Services B.V.

• Binatta

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol phosphate	38.285 mg

  ATC code: N02AX06

  Manufacturer: Centrafarm Services B.V.

• Binatta

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol phosphate	76.57 mg

  ATC code: N02AX06

  Manufacturer: Centrafarm Services B.V.

• Binatta

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol phosphate	229.709 mg

  ATC code: N02AX06

  Manufacturer: Centrafarm Services B.V.

• Binatta

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol phosphate	306.279 mg

  ATC code: N02AX06

  Manufacturer: Centrafarm Services B.V.

• Binatta

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol phosphate	382.848 mg

  ATC code: N02AX06

  Manufacturer: Centrafarm Services B.V.

• Palexia

  Form: tablets, film-coated

  Active substance	Dosage
  tapentadol	100 mg

  ATC code: N02AX06

  Manufacturer: Gruenenthal GmbH

• Palexia

  Form: solution, oral

  Active substance	Dosage
  tapentadol hydrochloride	4.66 mg/ml

  ATC code: N02AX06

  Manufacturer: Gruenenthal GmbH

• Palexia

  Form: solution, oral

  Active substance	Dosage
  tapentadol hydrochloride	23.3 mg/ml

  ATC code: N02AX06

  Manufacturer: Gruenenthal GmbH

• Palexia

  Form: tablets, film-coated

  Active substance	Dosage
  tapentadol	50 mg

  ATC code: N02AX06

  Manufacturer: Gruenenthal GmbH

• Palexia

  Form: tablets, film-coated

  Active substance	Dosage
  tapentadol	75 mg

  ATC code: N02AX06

  Manufacturer: Gruenenthal GmbH

• Palexia retard

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol	50 mg

  ATC code: N02AX06

  Manufacturer: Gruenenthal GmbH

• Palexia retard

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol	100 mg

  ATC code: N02AX06

  Manufacturer: Gruenenthal GmbH

• Palexia retard

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol	150 mg

  ATC code: N02AX06

  Manufacturer: Gruenenthal GmbH

• Palexia retard

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol	200 mg

  ATC code: N02AX06

  Manufacturer: Gruenenthal GmbH

• Palexia retard

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol	250 mg

  ATC code: N02AX06

  Manufacturer: Gruenenthal GmbH

• Palexia retard

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol hydrochloride	29.12 mg

  ATC code: N02AX06

  Manufacturer: Gruenenthal GmbH

• Tadomon

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol tartrate	41.9525 mg

  ATC code: N02AX06

  Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.

• Tadomon

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol tartrate	83.905 mg

  ATC code: N02AX06

  Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.

• Tadomon

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol tartrate	167.81 mg

  ATC code: N02AX06

  Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.

• Tadomon

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol tartrate	251.715 mg

  ATC code: N02AX06

  Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.

• Tadomon

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol tartrate	335.62 mg

  ATC code: N02AX06

  Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.

• Tadomon

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol tartrate	419.525 mg

  ATC code: N02AX06

  Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.